Relmada Therapeutics (RLMD) Net Equity Issued and Repurchased (2012 - 2026)
Relmada Therapeutics (RLMD) recorded Net Equity Issued and Repurchased of -$6.35 million in Q2 2026.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends
On a TTM basis, Relmada Therapeutics' Net Equity Issued and Repurchased came in at $150.29 million as of Jun 30, 2026; for FY2025, it was $93.64 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 26.8% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $246,747 in FY2024, $44.7 million in FY2022 (-75.8%) and $184.64 million in FY2021 (+546.0%).
- The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased in data going back to Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | -6.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.35 Mn |
| Mar 31, 2026 | 156.64 Mn |
| Mar 31, 2025 | 905,226.00 |
| Mar 31, 2024 | 246,747.00 |
| Dec 31, 2022 | 36,251.00 |
| Sep 30, 2022 | 619,092.00 |
| Jun 30, 2022 | 14.09 Mn |
| Mar 31, 2022 | 29.95 Mn |
| Sep 30, 2021 | -42,014.00 |
| Jun 30, 2021 | 21.53 Mn |
| Mar 31, 2021 | 1.93 Mn |
| Dec 31, 2020 | 944,153.00 |
| Sep 30, 2020 | 1.63 Mn |
| Jun 30, 2020 | 22.89 Mn |
| Mar 31, 2020 | 3.12 Mn |
| Dec 31, 2019 | 4,447.03 Bn |
| Sep 30, 2019 | 1.28 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Dec 31, 2018 | 3.90 Mn |
| Sep 30, 2018 | 404,500.00 |
API Access
Relmada Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();